抗CD20（利妥昔单抗）治疗特应性皮炎。 - Suppr

Suppr

超能文献

Anti-CD20 (rituximab) treatment for atopic eczema.

作者信息

Sedivá Anna, Kayserová Jana, Vernerová Eva, Poloucková Andrea, Capková Stepánka, Spísek Radek, Bartůnková Jirina

出版信息

J Allergy Clin Immunol. 2008 Jun;121(6):1515-6; author reply 1516-7. doi: 10.1016/j.jaci.2008.03.007. Epub 2008 Apr 14.

DOI:10.1016/j.jaci.2008.03.007

PMID:18410962

Abstract

摘要

相似文献

Anti-CD20 (rituximab) treatment for atopic eczema.

J Allergy Clin Immunol. 2008 Jun;121(6):1515-6; author reply 1516-7. doi: 10.1016/j.jaci.2008.03.007. Epub 2008 Apr 14.

Anti-CD20 (rituximab) treatment improves atopic eczema.

J Allergy Clin Immunol. 2008 Jan;121(1):122-8. doi: 10.1016/j.jaci.2007.11.016.

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

J Allergy Clin Immunol. 2007 Nov;120(5):1223-5. doi: 10.1016/j.jaci.2007.08.060. Epub 2007 Oct 22.

Omalizumab efficacy in a girl with atopic eczema.

Allergy. 2010 Feb;65(2):278-9. doi: 10.1111/j.1398-9995.2009.02153.x. Epub 2009 Oct 1.

Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.

South Med J. 2010 Jun;103(6):554-8. doi: 10.1097/SMJ.0b013e3181de0cf6.

Omalizumab for patients with severe and therapy-refractory atopic eczema?

Curr Allergy Asthma Rep. 2008 May;8(3):179-80. doi: 10.1007/s11882-008-0029-3.

Omalizumab treatment in severe adult atopic dermatitis.

Asian Pac J Allergy Immunol. 2011 Dec;29(4):357-60.

Efficacy of anti-IgE therapy in patients with atopic dermatitis.

J Am Acad Dermatol. 2006 Jul;55(1):168-70. doi: 10.1016/j.jaad.2005.12.045.

Suppression of atopic-like dermatitis by treatment with antibody to lymphocyte function-associated antigen-1 in NC/Nga mouse.

Eur J Pharmacol. 2004 Nov 3;504(1-2):113-7. doi: 10.1016/j.ejphar.2004.09.035.

Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.

J Dtsch Dermatol Ges. 2010 Dec;8(12):990-8. doi: 10.1111/j.1610-0387.2010.07497.x.

引用本文的文献

B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis.

J Clin Med. 2021 Oct 2;10(19):4577. doi: 10.3390/jcm10194577.

Update on the Pathogenesis and Therapy of Atopic Dermatitis.

Clin Rev Allergy Immunol. 2021 Dec;61(3):324-338. doi: 10.1007/s12016-021-08880-3. Epub 2021 Aug 2.

IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis.

Clin Transl Allergy. 2020 Aug 3;10:34. doi: 10.1186/s13601-020-00338-7. eCollection 2020.

Childhood atopic dermatitis: current developments, treatment approaches, and future expectations.

Turk J Med Sci. 2019 Aug 8;49(4):963-984. doi: 10.3906/sag-1810-105.

Clinical approach to the patient with refractory atopic dermatitis.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):23-33.e1. doi: 10.1016/j.anai.2017.09.061.

The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.

Inflamm Regen. 2017 Jun 5;37:14. doi: 10.1186/s41232-017-0044-7. eCollection 2017.

Systemic Treatment of Adult Atopic Dermatitis: A Review.

Dermatol Ther (Heidelb). 2017 Mar;7(1):1-23. doi: 10.1007/s13555-016-0170-1. Epub 2016 Dec 26.

Biological Treatments in Atopic Dermatitis.

J Clin Med. 2015 Apr 3;4(4):593-613. doi: 10.3390/jcm4040593.

Treatment of Eczema: Corticosteroids and Beyond.

Clin Rev Allergy Immunol. 2016 Dec;51(3):249-262. doi: 10.1007/s12016-015-8486-7.

[Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].

Hautarzt. 2015 Feb;66(2):108-13. doi: 10.1007/s00105-014-3575-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Anti-CD20 (rituximab) treatment for atopic eczema.

J Allergy Clin Immunol. 2008 Jun;121(6):1515-6; author reply 1516-7. doi: 10.1016/j.jaci.2008.03.007. Epub 2008 Apr 14.

Anti-CD20 (rituximab) treatment improves atopic eczema.

J Allergy Clin Immunol. 2008 Jan;121(1):122-8. doi: 10.1016/j.jaci.2007.11.016.

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

J Allergy Clin Immunol. 2007 Nov;120(5):1223-5. doi: 10.1016/j.jaci.2007.08.060. Epub 2007 Oct 22.

Omalizumab efficacy in a girl with atopic eczema.

Allergy. 2010 Feb;65(2):278-9. doi: 10.1111/j.1398-9995.2009.02153.x. Epub 2009 Oct 1.

Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.

South Med J. 2010 Jun;103(6):554-8. doi: 10.1097/SMJ.0b013e3181de0cf6.

Omalizumab for patients with severe and therapy-refractory atopic eczema?

Curr Allergy Asthma Rep. 2008 May;8(3):179-80. doi: 10.1007/s11882-008-0029-3.

Omalizumab treatment in severe adult atopic dermatitis.

Asian Pac J Allergy Immunol. 2011 Dec;29(4):357-60.

Efficacy of anti-IgE therapy in patients with atopic dermatitis.

J Am Acad Dermatol. 2006 Jul;55(1):168-70. doi: 10.1016/j.jaad.2005.12.045.

Suppression of atopic-like dermatitis by treatment with antibody to lymphocyte function-associated antigen-1 in NC/Nga mouse.

Eur J Pharmacol. 2004 Nov 3;504(1-2):113-7. doi: 10.1016/j.ejphar.2004.09.035.

Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.

J Dtsch Dermatol Ges. 2010 Dec;8(12):990-8. doi: 10.1111/j.1610-0387.2010.07497.x.

引用本文的文献

B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis.

J Clin Med. 2021 Oct 2;10(19):4577. doi: 10.3390/jcm10194577.

Update on the Pathogenesis and Therapy of Atopic Dermatitis.

Clin Rev Allergy Immunol. 2021 Dec;61(3):324-338. doi: 10.1007/s12016-021-08880-3. Epub 2021 Aug 2.

IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis.

Clin Transl Allergy. 2020 Aug 3;10:34. doi: 10.1186/s13601-020-00338-7. eCollection 2020.

Childhood atopic dermatitis: current developments, treatment approaches, and future expectations.

Turk J Med Sci. 2019 Aug 8;49(4):963-984. doi: 10.3906/sag-1810-105.

Clinical approach to the patient with refractory atopic dermatitis.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):23-33.e1. doi: 10.1016/j.anai.2017.09.061.

The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.

Inflamm Regen. 2017 Jun 5;37:14. doi: 10.1186/s41232-017-0044-7. eCollection 2017.

Systemic Treatment of Adult Atopic Dermatitis: A Review.

Dermatol Ther (Heidelb). 2017 Mar;7(1):1-23. doi: 10.1007/s13555-016-0170-1. Epub 2016 Dec 26.

Biological Treatments in Atopic Dermatitis.

J Clin Med. 2015 Apr 3;4(4):593-613. doi: 10.3390/jcm4040593.

Treatment of Eczema: Corticosteroids and Beyond.

Clin Rev Allergy Immunol. 2016 Dec;51(3):249-262. doi: 10.1007/s12016-015-8486-7.

[Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].

Hautarzt. 2015 Feb;66(2):108-13. doi: 10.1007/s00105-014-3575-8.